Covered recipient · General Payments record
LINDSAY MORGAN DYER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$1,038.11
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $684.24 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $167.73 | 9 |
| ABBVIE INC. | $167.18 | 13 |
| Acerta Pharma LLC | $81.31 | 4 |
| PFIZER INC. | $79.65 | 5 |
| Corcept Therapeutics | $75.87 | 1 |
| Axsome Therapeutics, Inc. | $59.75 | 1 |
| Exact Sciences Corporation | $20.02 | 1 |
| Supernus Pharmaceuticals, Inc. | $18.69 | 1 |
| Novo Nordisk AS | $14.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.77 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054982 | CMS |
| ABBVIE INC. | $9.40 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054984 | CMS |
| ABBVIE INC. | $15.42 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054986 | CMS |
| ABBVIE INC. | $8.66 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054988 | CMS |
| ABBVIE INC. | $15.23 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054990 | CMS |
| ABBVIE INC. | $19.12 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054992 | CMS |
| ABBVIE INC. | $7.30 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054994 | CMS |
| ABBVIE INC. | $30.37 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054996 | CMS |
| ABBVIE INC. | $9.15 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107054998 | CMS |
| ABBVIE INC. | $18.77 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107055000 | CMS |
| ABBVIE INC. | $10.39 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107055002 | CMS |
| ABBVIE INC. | $9.73 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107055004 | CMS |
| ABBVIE INC. | $4.87 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107055006 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.05 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104674843 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.74 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104611932 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.74 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104250049 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.78 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104330164 | CMS |
| Axsome Therapeutics, Inc. | $59.75 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148384784 | CMS |
| Corcept Therapeutics | $75.87 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117771405 | CMS |
| Exact Sciences Corporation | $20.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114534174 | CMS |
| Lilly USA, LLC | $54.88 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765997 | CMS |
| Lilly USA, LLC | $16.59 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765999 | CMS |
| Lilly USA, LLC | $24.51 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740788 | CMS |
| Lilly USA, LLC | $3.42 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752879 | CMS |
| Lilly USA, LLC | $7.42 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799356 | CMS |
| Lilly USA, LLC | $21.56 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135793117 | CMS |
| Lilly USA, LLC | $7.86 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752877 | CMS |
| Lilly USA, LLC | $14.91 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740786 | CMS |
| Lilly USA, LLC | $16.58 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135817124 | CMS |
| Novo Nordisk Inc | $14.04 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100306103 | CMS |
| PFIZER INC. | $15.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131154252 | CMS |
| PFIZER INC. | $18.42 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131238789 | CMS |
| PFIZER INC. | $15.89 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131473967 | CMS |
| PFIZER INC. | $13.23 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132121028 | CMS |
| PFIZER INC. | $16.95 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132077937 | CMS |
| Supernus Pharmaceuticals, Inc. | $18.69 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147816060 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.